News | January 07, 2024
Pharmaids Pharmaceuticals to acquire Adita Bio Sys in share swap
The acquisition of the shares of Adita result in growth opportunities in line with strategic objectives of the company
The acquisition of the shares of Adita result in growth opportunities in line with strategic objectives of the company
Dedicates upgraded National Centre for Disease Control, Delhi and a Temporary Regional Branch of NCDC to the nation
AMI to become part of Enpro’s Sealing Technologies Segment
Dr. Reddy's will make a US$ 7.5 million upfront payment to Coya
South Asia’s largest Trade Fair for pharma brought together over 50,000 visitors from across the globe, more than 1,500 exhibitors showcasing 10,000+ products and representation from over 80 countries
Almost 300 million people globally have chronic hepatitis B
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
New Molecular biology lab launched, AIIA increased its work scope in form of MoUs
Profit after tax (before exceptional items) up 23% to Rs 215 crores
The USFDA inspectors issued the observations after a product pre-approval inspection of the biologics facility in Bachupally
Subscribe To Our Newsletter & Stay Updated
